These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8827791)
1. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives. Cameron OG; Smith CB; Nesse RM; Hill EM; Hollingsworth PJ; Abelson JA; Hariharan M; Curtis GC Psychosom Med; 1996; 58(4):289-301. PubMed ID: 8827791 [TBL] [Abstract][Full Text] [Related]
2. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422 [TBL] [Abstract][Full Text] [Related]
3. Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal. Braune S; Albus M; Fröhler M; Höhn T; Scheibe G Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):86-92. PubMed ID: 7948059 [TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenergic receptor sensitivity in panic disorder: II. Cortisol response to clonidine stimulation in panic disorder. Brambilla F; Bellodi L; Arancio C; Nobile P; Perna G Psychoneuroendocrinology; 1995; 20(1):11-9. PubMed ID: 7838899 [TBL] [Abstract][Full Text] [Related]
5. Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety. Cameron OG; Smith CB; Hollingsworth PJ; Nesse RM; Curtis GC Arch Gen Psychiatry; 1984 Dec; 41(12):1144-8. PubMed ID: 6095785 [TBL] [Abstract][Full Text] [Related]
6. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder. Brambilla F; Perna G; Garberi A; Nobile P; Bellodi L Psychoneuroendocrinology; 1995; 20(1):1-9. PubMed ID: 7838898 [TBL] [Abstract][Full Text] [Related]
7. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719 [TBL] [Abstract][Full Text] [Related]
8. Platelet alpha 2 adrenoreceptors in chronic congestive heart failure. Weiss RJ; Tobes M; Wertz CE; Smith CB Am J Cardiol; 1983 Jul; 52(1):101-5. PubMed ID: 6305182 [TBL] [Abstract][Full Text] [Related]
9. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors. Grunhaus LJ; Cameron O; Pande AC; Haskett RF; Hollingsworth PJ; Smith CB Acta Psychiatr Scand; 1990 Mar; 81(3):216-9. PubMed ID: 2160772 [TBL] [Abstract][Full Text] [Related]
10. Personality dimensions in panic disorder before and after effective treatment. Starcevic V; Uhlenhuth EH Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608 [No Abstract] [Full Text] [Related]
11. Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures. Albus M; Zahn TP; Breier A Eur Arch Psychiatry Clin Neurosci; 1992; 241(6):337-44. PubMed ID: 1504110 [TBL] [Abstract][Full Text] [Related]
12. Do panic symptoms during periods of remission predict relapse of panic disorder? Weisberg RB; Machan JT; Dyck IR; Keller MB J Nerv Ment Dis; 2002 Mar; 190(3):190-7. PubMed ID: 11923654 [TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Carr DB; Sheehan DV; Surman OS; Coleman JH; Greenblatt DJ; Heninger GR; Jones KJ; Levine PH; Watkins WD Am J Psychiatry; 1986 Apr; 143(4):483-94. PubMed ID: 2869703 [TBL] [Abstract][Full Text] [Related]
15. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine. Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579 [TBL] [Abstract][Full Text] [Related]
16. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder. Klein E; Zinder O; Colin V; Zilberman I; Levy N; Greenberg A; Lenox RH Acta Psychiatr Scand; 1995 Dec; 92(6):399-408. PubMed ID: 8837965 [TBL] [Abstract][Full Text] [Related]
18. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619 [TBL] [Abstract][Full Text] [Related]
19. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Charney DS; Heninger GR Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083 [TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity to inhalation of carbon dioxide and panic attacks. Perna G; Gabriele A; Caldirola D; Bellodi L Psychiatry Res; 1995 Aug; 57(3):267-73. PubMed ID: 7501737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]